COMMUNIQUÉS West-GlobeNewswire

-
InflaRx to Participate in Upcoming Investor Conferences
22/05/2025 -
Descriptif du Programme de Rachat d’Actions Pouvant Être Mis en Œuvre dans le Cadre du Contrat de Liquidité Conclu avec Kepler Chevreux
22/05/2025 -
Introducing Y'all's Beer: A True Taste of Texas from Revolver Brewing
22/05/2025 -
BetterLife Provides Comments on CEO’s Share Position Ownership and Recent BCSC Press Release
22/05/2025 -
Avalyn to Participate in the Jefferies Global Healthcare Conference in June
22/05/2025 -
Sofwave to Participate in Jefferies Global Healthcare Conference
22/05/2025 -
Nanox Announces First Quarter 2025 Financial Results and Provides Business Updates
22/05/2025 -
Sagimet Biosciences to Host Virtual KOL Event, “Evaluating the Synergistic Potential of a Combination of Denifanstat and Resmetirom for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH)” on May 29, 2025
22/05/2025 -
Sequel Med Tech to Integrate twiist Automated Insulin Delivery (AID) System with Abbott’s Future Dual Glucose-Ketone Sensor
22/05/2025 -
Huit jeunes talents honorés lors des Prix Fiera Capital 2025 pour la diversité, l’équité et l’inclusion dans la recherche en santé
22/05/2025 -
Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01
22/05/2025 -
LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®
22/05/2025 -
AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
22/05/2025 -
Windtree Therapeutics Announces Istaroxime Cardiogenic Shock SCAI Stage C Phase 2 Study Planned Interim Analysis Results Targeted for July 2025
22/05/2025 -
Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System
22/05/2025 -
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing
22/05/2025 -
Biodexa Announces Award of Additional $3.0M Grant from CPRIT to Support Registrational eRapa Phase 3 Program in FAP Brings Total CPRIT Grant Funding for eRapa Phase 3 Program to $20.0M
22/05/2025 -
Orion to host Capital Markets Day today, 22 May 2025, in Helsinki
22/05/2025 -
PCI Biotech: Minutes of Annual General Meeting 2025
22/05/2025
Pages